News

Find updates on the work of our researchers here, as well as news about recent advances in Alzheimer's science, funding and awareness.

BRAIN Initiative and RAND Study: An Assessment

Over the last several days, two important announcements pertaining to Alzheimer's and other neurological diseases have been made.

Dementia Costs On Par with Cancer and Heart Disease

According to a new RAND study published today in the New England Journal of Medicine, dementia care costs are now comparable to those of heart disease and cancer. And unlike most chronic diseases, rates of dementia in the population are rising rapidly. The study estimates that about 3.8 million Americans currently suffer from dementia, and predicts that this number will climb to 9.1 million by 2040. The cost of the disease to the country will rise proportionally if a cure is not found.

Reprogramming Cells to Understand Alzheimer's Disease

Collaboration with the New York Stem Cell Foundation will involve using skin samples and brain imaging to identify causes and cures

Stem Cells Accelerate Research & Drug Discovery

Washington—Uncovering the cure for Alzheimer’s disease at a rate never before possible and giving individuals a way to better understand their chances of facing Alzheimer’s are the outcomes of new advances in stem cell research from the Cure Alzheimer’s Fund (CAF) Stem Cell Research Consortium that use skin samples to identify potential therapies for the disease.

Senior Vice President Sally Rosenfield Joins Women Against Alzheimer’s Network

WASHINGTON –Joining as the newest member of the Founding Board for the Women Against Alzheimer’s Network is Senior Vice President of Cure Alzheimer’s Fund, Sally Rosenfield.

Bringing together women from across the country who are leading the way in Alzheimer’s research, the Women Against Alzheimer’s Founding Network focuses on “harness[ing] the power of women” to build an “aggressive plan to prevent and treat Alzheimer’s disease.”

National Plan to Address Alzheimer's Disease

Cure Alzheimer’s Fund is grateful to President Obama for the Administration’s continued commitment to curing Alzheimer’s disease. With the implementation of the first ever National Plan To End Alzheimer’s Disease, to which Cure Alzheimer’s Fund was a contributor, and his specific targeting of the disease last night in the State of the Union address, President Obama has highlighted a national resolve to defeat this disease.

Cure Alzheimer’s Fund Receives Highest Rating from Charity Navigator

Cure Alzheimer’s Fund has been awarded the highest rating for sound fiscal management and commitment to accountability and transparency by Charity Navigator, the country’s largest and most-utilized independent evaluator of charities.

Drs. Marc Tessier-Lavigne and Robert Malenka Join Scientific Advisory Board

Cure Alzheimer's Fund (CAF) welcomes two new Scientific Advisory Board (SAB) members: Marc Tessier-Lavigne, Ph.D., president of The Rockefeller University, and former CAF Research Consortium member Robert C. Malenka, M.D., Ph.D., of Stanford University.

Featured Researcher: Giuseppina Tesco, M.D., Ph.D.

Meet Dr. Giuseppina Tesco, Cure Alzheimer’s Funded researcher, and assistant professor of neuroscience, Alzheimer’s Disease Research Laboratory, Department of Neuroscience, Tufts University School of Medicine.

Early Days

Can Venture Capital Help Cure Alzheimer's Disease?

A Pittsburgh philanthropist and retired Mellon exec thinks so. In 1988, Jeffrey L. Morby left American Express to join the management team tapped to rescue the nearly bankrupt Mellon Bank. After helping turn Mellon around, he retired at 59, but Morby has hardly been wiling away the time.